Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Pediatric Hematology and Oncology
|
November 30, 2012
Effect of weight on outcomes of children undergoing hematopoietic cell transplantation
Laura C Myers, Pengling Sun, Lisa L Brennan, et al.
Journal of Molecular Neuroscience : MN
|
September 28, 2013
Activating transcription factor 4 modulates BDNF release from microglial cells
Pengling Sun, Xiangnan Li, Chengwen Chen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 10, 2026
Management of breakthrough bleeds and surgical procedures in participants with hemophilia A or B without inhibitors receiving marstacimab prophylaxis in the phase 3 BASIS study
Johnny Mahlangu, Davide Matino, Olga Benitez Hidalgo, et al.
Free Radical Research
|
April 9, 2009
Hydrogen-rich saline protects against intestinal ischemia/reperfusion injury in rats
Xingfeng Zheng, Yanfei Mao, Jianmei Cai, et al.
Blood
|
December 6, 2025
Efficacy and Safety of Marstacimab Prophylaxis in Hemophilia A/B With Inhibitors: Results from the Phase 3 BASIS Trial
Davide Matino, Suchitra Acharya, Carrie Turich Taylor, et al.
Therapeutic Advances in Hematology
|
June 18, 2026
A plain language summary of the BASIS study looking at people living with severe hemophilia A or B with inhibitors and being treated with marstacimab
Davide Matino, Suchitra S Acharya, Carrie Turich Taylor, et al.
Molecular & Cellular Proteomics : MCP
|
March 13, 2013
Extending the mannose 6-phosphate glycoproteome by high resolution/accuracy mass spectrometry analysis of control and acid phosphatase 5-deficient mice
David E Sleat, Pengling Sun, Jennifer A Wiseman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 24, 2019
Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmas
Sunita Patel-Hett, Erika J Martin, Bassem M Mohammed, et al.
British Journal of Haematology
|
August 23, 2022
A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia
Johnny N Mahlangu, Jose Luis Lamas, Juan Cristobal Morales, et al.
Pediatric Blood & Cancer
|
May 15, 2013
Predictors of neoplastic disease in children with isolated pituitary stalk thickening
Nathan J Robison, Sanjay P Prabhu, Pengling Sun, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Pediatric Hematology and Oncology
|
November 30, 2012
Effect of weight on outcomes of children undergoing hematopoietic cell transplantation
Laura C Myers, Pengling Sun, Lisa L Brennan, et al.
Journal of Molecular Neuroscience : MN
|
September 28, 2013
Activating transcription factor 4 modulates BDNF release from microglial cells
Pengling Sun, Xiangnan Li, Chengwen Chen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 10, 2026
Management of breakthrough bleeds and surgical procedures in participants with hemophilia A or B without inhibitors receiving marstacimab prophylaxis in the phase 3 BASIS study
Johnny Mahlangu, Davide Matino, Olga Benitez Hidalgo, et al.
Free Radical Research
|
April 9, 2009
Hydrogen-rich saline protects against intestinal ischemia/reperfusion injury in rats
Xingfeng Zheng, Yanfei Mao, Jianmei Cai, et al.
Blood
|
December 6, 2025
Efficacy and Safety of Marstacimab Prophylaxis in Hemophilia A/B With Inhibitors: Results from the Phase 3 BASIS Trial
Davide Matino, Suchitra Acharya, Carrie Turich Taylor, et al.
Therapeutic Advances in Hematology
|
June 18, 2026
A plain language summary of the BASIS study looking at people living with severe hemophilia A or B with inhibitors and being treated with marstacimab
Davide Matino, Suchitra S Acharya, Carrie Turich Taylor, et al.
Molecular & Cellular Proteomics : MCP
|
March 13, 2013
Extending the mannose 6-phosphate glycoproteome by high resolution/accuracy mass spectrometry analysis of control and acid phosphatase 5-deficient mice
David E Sleat, Pengling Sun, Jennifer A Wiseman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 24, 2019
Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmas
Sunita Patel-Hett, Erika J Martin, Bassem M Mohammed, et al.
British Journal of Haematology
|
August 23, 2022
A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia
Johnny N Mahlangu, Jose Luis Lamas, Juan Cristobal Morales, et al.
Pediatric Blood & Cancer
|
May 15, 2013
Predictors of neoplastic disease in children with isolated pituitary stalk thickening
Nathan J Robison, Sanjay P Prabhu, Pengling Sun, et al.
Page
of 3